Immune modulators as therapeutic agents for cutaneous T-cell lymphoma.
Rook
Alain H
AH
Department of Dermatology, The University of Pennsylvania School of Medicine, Philadelphia.
Benoit
Bernice
B
Kim
Ellen J
EJ
Vittorio
Carmela C
CC
Anshelevich
Aleksandra
A
Raphael
Brian A
BA
Introcaso
Camille E
CE
Gardner
Jennifer M
JM
Evans
Katherine G
KG
Morrissey
Kelly
K
Samimi
Sara
S
Musiek
Amy C
AC
Showe
Louise C
LC
Wasik
Mariusz A
MA
Wysocka
Maria
M
D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D016410:Lymphoma, T-Cell, Cutaneous / Q000188:drug therapy; D012878:Skin Neoplasms / Q000188:drug therapy
D007155:Immunologic Factors
J Am Acad Dermatol. 2010 Dec;63(6):975-83
20888065
J Am Acad Dermatol. 2006 Nov;55(5):807-13
17052486
Int J Nanomedicine. 2006;1(3):255-62
17717966
Blood. 2004 Dec 15;104(13):4142-9
15328153
Blood. 2008 Sep 15;112(6):2484-8
18559673
Arch Dermatol. 2002 Sep;138(9):1137-9
12224972
Am J Hematol. 2007 Sep;82(9):792-7
17546636
J Invest Dermatol. 2006 Mar;126(3):690-2
16410788
Clin Lymphoma Myeloma. 2006 Nov;7(3):226-32
17229339
J Invest Dermatol. 2008 Feb;128(2):473-80
17713571
Clin Lymphoma Myeloma. 2007 Sep;7(8):524-34
18021470
J Natl Cancer Inst. 1990 Feb 7;82(3):208-12
2104937
Immunity. 2008 Nov 14;29(5):691-703
18976936
J Clin Invest. 2005 Apr;115(4):798-812
15841167
Dermatol Ther. 2003;16(4):311-21
14686974
Blood. 1999 Aug 1;94(3):902-8
10419880
Arch Dermatol. 2005 Sep;141(9):1176-8
16172331
Arch Dermatol. 2005 Mar;141(3):315-21
15781672